在急性心肌梗塞中常规使用螺旋
Sanjit S Jolly1,2, Marc-André d'Entremont1,2,3, Bertram Pitt4
1Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
The New England journal of medicine
|November 18, 2024
概括
在心肌梗塞后的患者中,螺旋龙并没有显著减少心血管死亡或心力衰竭. 这项研究发现,在这种患者群体中,螺旋龙在预防重大心血管不良事件方面没有显著的益处.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 矿物质皮质类受体抗剂 (MRA) 是已确立的治疗方法,用于降低心力衰竭心肌梗塞 (MI) 后心力衰竭患者的死亡率.
- 在没有确定的心力衰竭的情况下,在更广泛的后心脏病患者群体中常规使用螺旋,MRA仍然不确定.
研究的目的:
- 为了研究螺旋龙在降低心血管死亡率和心力衰竭事件的疗效,在心肌梗塞后的患者.
- 评估螺旋龙对主要心血管不良事件的综合影响,包括心脏病发作,中风,心力衰竭和心血管死亡.
主要方法:
- 进行了一项多中心,随机,双盲,安慰剂对照试验,采用2x2因数设计.
- 经过皮肤冠状动脉干预的7062名心脏病后患者被随机分配给接受螺旋龙或安慰剂.
- 主要结局包括心血管死亡或新发/恶化的心力衰竭的复合,以及第一次发生心脏病发作,中风,新发/恶化的心力衰竭或心血管死亡的复合.
主要成果:
- 与安慰剂 (HR 0.91,P=0.51) 相比,螺旋龙并没有显著降低第一个主要结果 (心血管死亡或新的/恶化的心力衰竭).
- 第二个主要结局 (心血管死亡,心脏病发作,中风或新发/恶化的心力衰竭的综合结局) 也没有被螺旋乳显著降低 (HR 0.96,P=0.60).
- 在螺旋和安慰剂组之间,严重的不良事件是可比的.
结论:
- 在心肌梗塞后的患者中,常规使用螺旋龙并没有导致心血管死亡,心力衰竭或其他主要心血管不良事件的显著减少.
- 这些发现表明,在这种特定的患者群体中,螺旋可能不会提供超出已知的治疗方法的额外益处.
相关概念视频
01:14Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
01:26Heart Failure Drugs: Inotropic Agents
523
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
523
01:22Heart Failure Drugs: Diuretics
345
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
911
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
911